RGD-Based Fluorescence to Assess Placental Angiogenesis.

Area of Science:

• Reproductive biology
• Vascular biology
• Medical imaging

Background:

• Normal fetal growth and placental development rely on angiogenesis at the fetomaternal interface.
• Current in vivo methods for assessing placental angiogenesis are lacking.
• Accurate assessment of placental neovascularization is crucial for understanding pregnancy outcomes.

Purpose of the Study:

• To develop and validate a quantitative, noninvasive in vivo method for measuring placental neovascularization in gravid mice.
• To assess fetomaternal angiogenic activity throughout pregnancy.
• To provide insights into pregnancy outcomes through placental angiogenesis assessment.

Main Methods:

• Utilized a fluorescent molecule, Angiostamp700, targeting the alpha v beta 3 (αvβ3) integrin.
• Employed a noninvasive in vivo imaging technique in gravid mice.
• Quantified neovascularization based on Angiostamp700 fluorescence at the fetomaternal interface.

Main Results:

• Successfully established a quantitative method to measure placental neovascularization in vivo.
• Demonstrated the ability to assess fetomaternal angiogenic activity noninvasively.
• The method provides data relevant to pregnancy outcomes.

Conclusions:

• A novel, noninvasive in vivo method for quantifying placental neovascularization has been developed.
• This technique allows for the assessment of angiogenic activity at the fetomaternal interface.
• The method holds promise for improving the understanding and monitoring of pregnancy outcomes.